BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 28610718)

  • 1. Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory effects and alleviate clinical symptoms of atopic eczema.
    Oláh A; Szabó-Papp J; Soeberdt M; Knie U; Dähnhardt-Pfeiffer S; Abels C; Bíró T
    J Dermatol Sci; 2017 Oct; 88(1):67-77. PubMed ID: 28610718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts.
    Chicca A; Raduner S; Pellati F; Strompen T; Altmann KH; Schoop R; Gertsch J
    Int Immunopharmacol; 2009 Jul; 9(7-8):850-8. PubMed ID: 19303464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
    Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R
    J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream.
    Zirwas MJ; Barkovic S
    J Drugs Dermatol; 2017 Mar; 16(3):243-247. PubMed ID: 28301620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
    Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
    Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
    Bomstein Y; Rozenblat S
    J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria.
    Todd DA; Gulledge TV; Britton ER; Oberhofer M; Leyte-Lugo M; Moody AN; Shymanovich T; Grubbs LF; Juzumaite M; Graf TN; Oberlies NH; Faeth SH; Laster SM; Cech NB
    PLoS One; 2015; 10(5):e0124276. PubMed ID: 25933416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC/Nga murine model of atopic dermatitis.
    Park BK; Park YC; Jung IC; Kim SH; Choi JJ; Do M; Kim SY; Jin M
    J Ethnopharmacol; 2015 May; 165():54-60. PubMed ID: 25721805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema.
    Groene D; Martus P; Heyer G
    Exp Dermatol; 2001 Apr; 10(2):110-7. PubMed ID: 11260249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectoine-containing cream in the treatment of mild to moderate atopic dermatitis: a randomised, comparator-controlled, intra-individual double-blind, multi-center trial.
    Marini A; Reinelt K; Krutmann J; Bilstein A
    Skin Pharmacol Physiol; 2014; 27(2):57-65. PubMed ID: 23949258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
    Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
    Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a protein-free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients.
    Wollenberg A; Fölster-Holst R; Saint Aroman M; Sampogna F; Vestergaard C
    J Eur Acad Dermatol Venereol; 2018 Apr; 32 Suppl 1():1-15. PubMed ID: 29533490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver enzyme-mediated oxidation of Echinacea purpurea alkylamides: production of novel metabolites and changes in immunomodulatory activity.
    Cech NB; Tutor K; Doty BA; Spelman K; Sasagawa M; Raner GM; Wenner CA
    Planta Med; 2006 Dec; 72(15):1372-7. PubMed ID: 17054047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy.
    Micheli L; Maggini V; Ciampi C; Gallo E; Bogani P; Fani R; Pistelli L; Ghelardini C; Di Cesare Mannelli L; De Leo M; Firenzuoli F
    Phytother Res; 2023 May; 37(5):1911-1923. PubMed ID: 36578266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): A randomized, placebo-controlled clinical trial.
    Abbasi S; Kamalinejad M; Babaie D; Shams S; Sadr Z; Gheysari M; Askari VR; Rakhshandeh H
    Complement Ther Med; 2017 Dec; 35():85-91. PubMed ID: 29154073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.
    Nakashima C; Otsuka A; Kabashima K
    Exp Dermatol; 2018 Apr; 27(4):327-331. PubMed ID: 29524262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trial.
    Czarnowicki T; Dohlman AB; Malik K; Antonini D; Bissonnette R; Chan TC; Zhou L; Wen HC; Estrada Y; Xu H; Bryson C; Shen J; Lala D; Ma'ayan A; McGeehan G; Gregg R; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):631-640.e11. PubMed ID: 29567358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
    Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Multi-Action Emollient Plus Cream Improves Skin Barrier Function in Patients with Atopic Dermatitis: In vitro and Clinical Evidence.
    Quadri M; Lotti R; Bonzano L; Ciardo S; Guanti MB; Pellacani G; Pincelli C; Marconi A
    Skin Pharmacol Physiol; 2021; 34(1):8-18. PubMed ID: 33601378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.